Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in Castration-Resistant Prostate Cancer. Homo sapiens
收藏NIAID Data Ecosystem2026-03-09 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA312915
下载链接
链接失效反馈官方服务：
资源简介：
Illumina gene array analyses of prostate cancer cell lines that had acquired resistance to Enzalutamide (MDV3100). Overall design: mRNA analyses of four cell lines (CWR-R1, LAPC-4, LNCaP, and VCAP) cells that were either untreated, treated for 48hrs with Enz (short-term), or continuously grown in Enzalutamide for >6 months.
创建时间：
2016-02-23
